IonQ also continues to burn cash, with negative operating cash flow of $208.7 million through the first nine months of the ...

Biotech stocks have performed well this year. The SPDR S&P Biotech ETF -- an industry benchmark -- is up 21% this year. Two ...

Buy the penny stocks the pros are buying and ride the stock price higher. I’ll show you how to find the top penny stocks to watch, the ones billion-dollar money managers are buying and how to create a ...

The AI trade might have gotten a whole lot bumpier after rolling through big tech earnings season, but the boom still seems ...

As it turns out, select Wall Street analysts believe that these two stocks could gain at least 20% over the next year.

Digital health’s 2025 shape is pretty clear: money is flowing again, AI is getting absorbed into real workflows, and policy ...

Shares MSCI Austria ETF's 35% 7-month return, outpaces Eurozone stocks. Read here for EWO ETF's dividends, valuations, and ...

Enbridge has been a dividend darling for decades, but this dividend giant is offering a better return in the current market ...

Buffett has taken a highly conservative approach to the stock market in recent years. However, he bought these three stocks ...

The beauty care specialist posted a very modest increase on the top line.

Currently, Meta Platforms' stock trades at a forward price-to-earnings (P/E) multiple of around 24, based on analysts' ...

These companies have exceptional dividend track records. AbbVie is moving on from its Humira patent losses, and its portfolio ...